Gas7 attenuates hepatocellular carcinoma progression and chemoresistance through the PI3K/Akt signaling pathway

被引:2
|
作者
Liu, Wen-Feng [1 ,2 ,3 ]
Zhang, Qi-Wei [4 ]
Quan, Bing [1 ,2 ]
Zhang, Feng [1 ,2 ,3 ]
Li, Miao [1 ,2 ]
Lu, Shen-Xin [1 ,2 ]
Dong, Ling [3 ,5 ]
Yin, Xin [1 ,2 ,5 ]
Liu, Bin-Bin [1 ,2 ,5 ]
机构
[1] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China
[2] Natl Clin Res Ctr Intervent Med, Shanghai 200032, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, Shanghai 200032, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Intervent Radiol, Shanghai 200025, Peoples R China
[5] 136 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China
关键词
Gas7; PI3K/Akt signaling pathway; Hepatocellular carcinoma; HEMATOPOIETIC PROGENITORS; CELL-CYCLE; PROLIFERATION; CONTRIBUTES; MIGRATION; MLL-GAS7;
D O I
10.1016/j.cellsig.2023.110908
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Growth arrest-specific gene 7 (Gas7) was involved in various cellular functions, although its specific roles and molecular mechanisms in hepatocellular carcinoma (HCC) remained unclear. So the current study was to investigate the role of Gas7 in HCC. Our findings revealed that Gas7 was downregulated in various HCC cell lines and low Gas7 expression was associated with decreased overall survival in patients with HCC. Additionally, our functional assays showed that Gas7 inhibited cell proliferation and migration, induced cell cycle arrest, apoptosis, and autophagy, and enhanced oxaliplatin sensitivity by inhibiting the PI3K/Akt signaling pathway. We also observed that transcription factor Sp1 was responsible for inhibiting Gas7. These findings provide insights into the role and elucidated a potential mechanism of Gas7 in HCC progression and metastasis. It was also observed that the Sp1/Gas7/PI3K/Akt axis was critical for malignant phenotype and oxaliplatin sensitivity in HCC. Therefore, Gas7 can be considered as a prognostic predictor and therapeutic target for HCC.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
    Ye, Yanqing
    Liu, Maosheng
    Wu, Fengfei
    Ou, Shiyu
    Wang, Weidong
    Fei, Jieying
    Xie, Fang
    Bai, Lan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [2] TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
    Yanqing Ye
    Maosheng Liu
    Fengfei Wu
    Shiyu Ou
    Weidong Wang
    Jieying Fei
    Fang Xie
    Lan Bai
    European Journal of Medical Research, 28
  • [3] CURZERENE SUPPRESSES HEPATOCELLULAR CARCINOMA PROGRESSION THROUGH THE PI3K/AKT/MTOR PATHWAY
    Luo, Yihui
    Wang, Zhenchang
    Jiang, Jun'e
    Wu, Shanshan
    Zhai, Yang
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2024, 76 (04): : 173 - 184
  • [4] Small nucleolar RNA 42 facilitates the progression of hepatocellular carcinoma through PI3K/Akt signaling pathway
    Liu, Jing
    Deng, Jiuling
    Liang, Qing
    Yu, Yan
    Yang, Xu
    Sun, Guangchun
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2025, 44 (01)
  • [5] Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
    Yu, Xinxin
    Zheng, Yan
    Zhu, Xuchao
    Gao, Xiaomei
    Wang, Chaoqun
    Sheng, Yuanyuan
    Cheng, Wei
    Qin, Lunxiu
    Ren, Ning
    Jia, Huliang
    Dong, Qiongzhu
    ONCOLOGY LETTERS, 2018, 16 (04) : 5299 - 5308
  • [6] Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
    Wang, Houhong
    Chen, Wenli
    Cui, Yayun
    Gong, Huihui
    Tang, Amao
    AGING-US, 2023, 15 (15): : 7831 - 7843
  • [7] Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
    Huang, Lu
    Yang, Qiong
    Chen, Huihong
    Wang, Zhenggeng
    Liu, Qi
    Ai, Shuhua
    OPEN MEDICINE, 2022, 17 (01): : 626 - 637
  • [8] Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway
    Hui Shao
    Jingyan Chen
    Ali Li
    Lili Ma
    Yongzhi Tang
    Huazhong Chen
    Yongping Chen
    Junyan Liu
    Applied Biochemistry and Biotechnology, 2023, 195 : 5217 - 5237
  • [9] Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway
    Shao, Hui
    Chen, Jingyan
    Li, Ali
    Ma, Lili
    Tang, Yongzhi
    Chen, Huazhong
    Chen, Yongping
    Liu, Junyan
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2023, 195 (08) : 5217 - 5237
  • [10] COPS8 promotes hepatocellular carcinoma progression through the PI3K/AKT/mTOR pathway
    Yan, Xiaodong
    Li, Zhongmin
    Tian, Qing
    Zhang, Yamin
    ASIAN JOURNAL OF SURGERY, 2024, 47 (06) : 2947 - 2949